Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Sedana Medical

9.18 SEK

-1.61 %

Less than 1K followers

SEDANA

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-1.61 %
-14.04 %
-10.70 %
-13.23 %
-28.73 %
-41.38 %
-55.26 %
-88.94 %
+54.29 %

Sedana Medical operates in the medical technology industry and focuses on the development and manufacture of systems for inhalation anesthesia. The company's products are aimed at healthcare institutions and anesthesiologists. The business is global with a main presence in Europe, North America and Asia. Sedana Medical was founded in 2005 and is headquartered in Danderyd, Sweden.

Read more
Market cap
911.91M SEK
Turnover
1.73M SEK
Revenue
200.23M
EBIT %
-16.06 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
23/5
2026

Interim report Q1'26

27/5
2026

General meeting '26

17/7
2026

Interim report Q2'26

All
Webcasts
Press releases
ShowingAll content types
Press releaseyesterday

Sedana Medical meddelar att första patienten behandlats i Early Access Program i USA

Sedana Medical
Press releaseyesterday

Sedana Medical reports first patient treated in Early Access Program in the U.S.

Sedana Medical
Regulatory press release2/12/2026, 6:00 AM

Sedana Medical AB:s Bokslutskommuniké 2025

Sedana Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2/12/2026, 6:00 AM

Sedana Medical AB’s Year-end report 2025

Sedana Medical
Press release1/29/2026, 7:00 AM

Inbjudan till presentation av Sedana Medicals kvartalsrapport för fjärde kvartalet 2025

Sedana Medical
Press release1/29/2026, 7:00 AM

Invitation to presentation of Sedana Medical’s interim report for the fourth quarter 2025

Sedana Medical
Regulatory press release1/27/2026, 7:00 AM

Sedana Medical utser Mikael Haag till Chief Financial Officer (CFO)

Sedana Medical
Regulatory press release1/27/2026, 7:00 AM

Sedana Medical appoints Mikael Haag as Chief Financial Officer (CFO)

Sedana Medical
Regulatory press release12/19/2025, 4:30 PM

CFO Johan Spetz lämnar Sedana Medical

Sedana Medical
Regulatory press release12/19/2025, 4:30 PM

CFO Johan Spetz to leave Sedana Medical

Sedana Medical
Regulatory press release11/24/2025, 7:00 AM

Sedana Medical informerar om positivt pre-NDA-möte med FDA

Sedana Medical
Regulatory press release11/24/2025, 7:00 AM

Sedana Medical reports positive pre-NDA meeting with FDA

Sedana Medical
Regulatory press release10/24/2025, 5:00 AM

Sedana Medical AB:s Delårsrapport januari-september 2025

Sedana Medical
Regulatory press release10/24/2025, 5:00 AM

Sedana Medical AB’s Interim report January-September 2025

Sedana Medical
Regulatory press release10/21/2025, 10:47 AM

Finansinspektionen: Flaggningsmeddelande i Sedana Medical AB (publ)

Sedana Medical
Regulatory press release10/16/2025, 4:00 PM

Sedana Medicals valberedning inför årsstämman 2026

Sedana Medical
Regulatory press release10/16/2025, 4:00 PM

Sedana Medical’s Nomination Committee for the 2026 Annual General Meeting

Sedana Medical
Press release10/10/2025, 6:00 AM

Inbjudan till presentation av Sedana Medicals kvartalsrapport för tredje kvartalet 2025

Sedana Medical
Press release10/10/2025, 6:00 AM

Invitation to presentation of Sedana Medical’s interim report for the third quarter 2025

Sedana Medical
Regulatory press release7/18/2025, 5:00 AM

Sedana Medical AB:s Delårsrapport januari-juni 2025

Sedana Medical
Forum discussions
Sedana Medical AB doesn’t have its own thread, although I believe it’s on many investors’ radar or even in their portfolios, at least if they are focused on medtech stocks. The company was founded in 2005 and its headquarters are in Stockholm. The company specializes in sedation ...
8/3/2025, 1:08 PM
by Hawkmountdiver
7
The figures can be found in this latest interim report. Q2 / 2025 was a slightly weaker-than-expected quarter, which at least for a moment scared investors. storage.mfn.se sedana-medical-interim-report-q225.pdf
8/3/2025, 8:42 PM
by Hawkmountdiver
0
Read more on our forum
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.